Samrat Pharmachem (BOM:530125) Other Operating Expense: ₹94 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530125 Samrat Pharmachem Ltd BOM:530125
62 GF Score
Price ₹223.20
GF Value ₹355.46
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Samrat Pharmachem Other Operating Expense?

Samrat Pharmachem BOM:530125 +0.59% 62 Other Operating Expense is ₹94 Mil as of Jun. 2026. GuruFocus rates BOM:530125 with a GF Score™ of 62/100 and a GF Value™ of ₹355.46 (Possible Value Trap). The stock has 4 warning signs investors should review.

Samrat Pharmachem's Other Operating Expense for the three months ended in Jun. 2026 was ₹0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹94 Mil.

Samrat Pharmachem's quarterly Other Operating Expense increased from Dec. 2025 (₹-0 Mil) to Mar. 2026 (₹-0 Mil) and increased from Mar. 2026 (₹-0 Mil) to Jun. 2026 (₹0 Mil).

Samrat Pharmachem's annual Other Operating Expense increased from Mar. 2024 (₹3 Mil) to Mar. 2025 (₹4 Mil) but then declined from Mar. 2025 (₹4 Mil) to Mar. 2026 (₹2 Mil).

Samrat Pharmachem Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Samrat Pharmachem's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Samrat Pharmachem Other Operating Expense Chart

Samrat Pharmachem Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.99 3.01 2.78 3.51 2.31

Samrat Pharmachem Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -0.00 0.00
BOM:530125
62GF Score
Samrat Pharmachem Ltd BOM:530125
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Samrat Pharmachem Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of ₹94 Mil mean?
Samrat Pharmachem (BOM:530125) has a Other Operating Expense of ₹94 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Samrat Pharmachem and its competitors.
Is Samrat Pharmachem's Other Operating Expense too high?
Samrat Pharmachem's current Other Operating Expense is ₹94 Mil. Overall, Samrat Pharmachem has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Samrat Pharmachem's Other Operating Expense compare to DOW?
Samrat Pharmachem's Other Operating Expense of ₹94 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Chemicals company?
A good Other Operating Expense depends on the Chemicals industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Samrat Pharmachem and its competitors. Samrat Pharmachem's current Other Operating Expense is ₹94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Samrat Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Samrat Pharmachem (BOM:530125) is currently considered Possible Value Trap. The stock's GF Value™ is ₹355.46, compared to a current price of ₹223.20 — trading 37.2% below its estimated fair value. The current Other Operating Expense is ₹94 Mil. Samrat Pharmachem's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Samrat Pharmachem (BOM:530125), the current Other Operating Expense is ₹94 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Samrat Pharmachem (BOM:530125) Overvalued in 2026?

Based on GuruFocus' analysis, Samrat Pharmachem stock appears to be undervalued. The current stock price of ₹223.20 is trading 37.2% below its estimated GF Value™ of ₹355.46. GuruFocus considers Samrat Pharmachem to be Possible Value Trap.

Key valuation signals for BOM:530125:

  • Other Operating Expense: ₹94 Mil
  • GF Value™: ₹355.46 vs. price of ₹223.20 (37.2% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the BOM:530125 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Samrat Pharmachem Business Description

Address M. A. Road, 701/702, Business Square, Andheri (West), Mumbai, MH, IND, 400 058
Samrat Pharmachem Ltd is a producer of pharmaceutical chemicals. The principal activity of the company is to manufacture Iodine salts and bromine salts. Its product portfolio consists of potassium iodate, potassium iodide, methyl iodide, and copper iodide. Its products are used in various industries like pharmaceuticals and chemicals.
62GF Score

Get the complete analysis for BOM:530125

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹223.20
Price
₹355.46
GF Value